Observational studyAnnals of transplantation2017

Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study.

Olga Tronina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.